News
The latest AHA Today headline news stories.
The Food and Drug Administration today expanded its approval for remdesivir (Veklury) to include pediatric patients under age 12 who test positive for SARS-CoV-2 and are hospitalized or at high risk of progressing to severe COVID-19. The patient must be at least 28 days old and weigh at least…
Since the start of the COVID-19 pandemic, hospitals have experienced surging costs for labor, drugs, supplies, equipment and other resources required to care for patients, according to a new AHA report. Among other findings, between 2019 and 2021, labor expenses per patient rose 19.1%, with travel…
The AHA yesterday urged the Department of Justice to support legislation that would give health care workers the same legal protections as flight crews and airport workers.
The average monthly premium for consumers receiving an advance premium tax credit was $133, down from $164 in 2021.
Health and Human Services Secretary Xavier Becerra yesterday joined health ministers from Britain, Canada, France, Germany, Italy and Japan in strongly condemning Russia’s military attacks on Ukrainian health care facilities.
AHA and its Institute for Diversity and Health Equity encourage organizational health equity, diversity and inclusion leaders to complete the survey.
AHA today urged Congress to provide immediate additional support for hospitals and health systems as COVID-19 challenges persist.
The Health Resources and Services Administration yesterday released another $413 million in Provider Relief Fund “Phase 4” payments.
Philips Respironics and Adamis Pharmaceuticals announce recalls.
The Centers for Medicare & Medicaid Services yesterday issued guidance to clarify certain HIPAA protections and responsibilities.